InflaRx NV (IFRX)
1.33
-0.08
(-5.67%)
USD |
NASDAQ |
May 02, 16:00
1.33
0.00 (0.00%)
After-Hours: 18:18
InflaRx Cash from Investing (TTM): -19.16M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -19.16M |
| September 30, 2023 | -19.61M |
| June 30, 2023 | -23.37M |
| March 31, 2023 | -13.15M |
| December 31, 2022 | 20.42M |
| September 30, 2022 | -22.12M |
| June 30, 2022 | -19.67M |
| March 31, 2022 | 0.2751M |
| December 31, 2021 | -30.70M |
| September 30, 2021 | -0.6665M |
| June 30, 2021 | 4.410M |
| March 31, 2021 | 26.13M |
| December 31, 2020 | 24.40M |
| Date | Value |
|---|---|
| September 30, 2020 | 60.10M |
| June 30, 2020 | 25.85M |
| March 31, 2020 | 20.07M |
| December 31, 2019 | 22.77M |
| September 30, 2019 | 1.972M |
| June 30, 2019 | -88.16M |
| March 31, 2019 | -117.57M |
| December 31, 2018 | -117.43M |
| September 30, 2018 | -122.63M |
| June 30, 2018 | -10.15M |
| March 31, 2018 | -0.3199M |
| December 31, 2017 | -0.1892M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-88.16M
Minimum
Jun 2019
60.10M
Maximum
Sep 2020
-1.591M
Average
0.2751M
Median
Mar 2022
Cash from Investing (TTM) Benchmarks
| Affimed NV | -39.04M |
| MorphoSys AG | -- |
| BioNTech SE | -7.529B |
| Immatics NV | -33.98M |
| CureVac NV | -59.76M |